Trial intelligence / Profile preview

Additional Nitrate Therapy in Congestive Heart Failure with Cheyne-Stokes Respiration

DRKS00000402Phase 3Withdrawn

Sponsor
Heart and Diabetes Center North Rhine-Westphalia
Start
Jun 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of nitroglycerin in heart failure (HF), Cheyne-Stokes respiration (CSR), sponsored by Heart and Diabetes Center North Rhine-Westphalia. Planned start Jun 2010; status: withdrawn.

02

Drugs

nitroglycerin
03

Conditions

heart failure (HF)Cheyne-Stokes respiration (CSR)

Beyond the preview

Go deeper on DRKS00000402.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on DRKS00000402.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call